Sanofi (SNY) Cash from Financing Activities (2013 - 2026)

Sanofi (SNY) has 7 years of Cash from Financing Activities data on file, last reported at -$1.8 billion in Q1 2026.

• Quarterly Cash from Financing Activities fell 187.09% year-over-year to -$1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22.3 billion (down 234.57% YoY) and the FY2025 annual result came in at -$9.5 billion, down 54.22% from the prior year.
• Cash from Financing Activities rose to -$1.8 billion in Q1 2026 per SNY's latest filing, from -$9.6 billion in the prior quarter.
• The five-year high for Cash from Financing Activities was $825.6 million in Q1 2024, with the low at -$9.6 billion in Q4 2025.
• Average Cash from Financing Activities over 3 years is -$3.6 billion, with a median of -$3.1 billion recorded in 2026.
• The widest YoY moves for Cash from Financing Activities: up 55.13% in 2025, down 510.48% in 2025.
• Sanofi's Cash from Financing Activities stood at -$6.2 billion in 2024, then tumbled by 55.13% to -$9.6 billion in 2025, then jumped by 81.29% to -$1.8 billion in 2026.
• Business Quant data shows SNY's Cash from Financing Activities at -$1.8 billion in Q1 2026, -$9.6 billion in Q4 2025, and -$6.6 billion in Q3 2025.